Showing results (101-110 of 360) with videos related to
Sort By:
Pageof 36
Current Pharmaceutical Design|July 30, 2013
Pharmacoepigenomics: an interplay of epigenetic modulation of drug response and modulation of the epigenome by drugsShweta Mendiratta, Shruti Jain, Jayant Maini, et al.Future Medicinal Chemistry|May 10, 2017
Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rulesSayanti Brahmachari, Ashim Paul, Daniel Segal, et al.Nucleic Acids Research|May 25, 1988
Interruptions of (CG)n sequences by GG, TG and CA need not prevent B to Z transition in solutionR K Mishra, P K Latha, S K BrahmachariCureus|March 21, 2022
Synchronous Luminal A Ductal Carcinoma In Situ in a Recurrent Benign Phyllodes Tumor Diagnosed Preoperatively: An Unusual Presentation of a Rare NeoplasmSwagata Brahmachari, Meena Kumari, Tanya Sharma, et al.Pharmacogenomics|December 16, 2005
Pharmacogenomics: a path to predictive medicine for schizophreniaSimone Gupta, Sanjeev Jain, Samir K Brahmachari, et al.Molecular Biosystems|May 1, 2013
Social networks to biological networks: systems biology of Mycobacterium tuberculosisRohit Vashisht, Anshu Bhardwaj, Osdd Consortium, et al.Health Research Policy and Systems|January 4, 2018
Engaging stakeholders: lessons from the use of participatory tools for improving maternal and child care health servicesElizabeth Ekirapa-Kiracho, Upasona Ghosh, Rittika Brahmachari, et al.Molecular Biosystems|June 16, 2012
A simple method for incorporating dynamic effects of intronic miRNA mediated regulationSucheta Gokhale, Manoj Hariharan, Samir K Brahmachari, et al.Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials|June 1, 2016
One-pot green synthesis of biologically relevant novel spiro[indolin-2-one-3,4'-pyrano[2,3-c]pyrazoles] and studies on their spectral and X-ray crystallographic behaviorsSakshi Sharma, Goutam Brahmachari, Rajni Kant, et al.Scientific Reports|April 21, 2017
Data Intensive Genome Level Analysis for Identifying Novel, Non-Toxic Drug Targets for Multi Drug Resistant Mycobacterium tuberculosisDivneet Kaur, Rintu Kutum, Debasis Dash, et al.Pageof 36